Regorafenib versus TAS-102 as Salvage-line in patients with colorectal cancer refractory to standard chemotherapies: a multicenter observational study

ABSTRACT: Primary outcome(s): Overall survival

DISEASE(S): Colorectal Cancer

PROVIDER: 2635694 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR